pc ¹öÀüÀ¸·Î À̵¿ Áß [½ÃÀ庸°í¼­]¼¼°èÀÇ ¸ÖƼÆĶó¹ÌÅÍ È¯ÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀå : ÁßÁõµµ ·¹º§º°, ±â±âº°, ÃÖÁ¾ »ç¿ëÀÚº°, ±¹°¡º°, Áö¿ªº° - »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À², ¿¹Ãø(2023-2030³â)
¼¼°èÀÇ ¸ÖƼÆĶó¹ÌÅÍ È¯ÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀå : ÁßÁõµµ ·¹º§º°, ±â±âº°, ÃÖÁ¾ »ç¿ëÀÚº°, ±¹°¡º°, Áö¿ªº° - »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À², ¿¹Ãø(2023-2030³â)
Multiparameter Patient Monitoring System Market with COVID-19 Impact Analysis, By Acuity Level, By Device, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
»óÇ°ÄÚµå : 1320123
¸®¼­Ä¡»ç : AnalystView Market Insights
¹ßÇàÀÏ : 2023³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 256 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,250 £Ü 4,784,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅؽºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 4,650 £Ü 6,845,000
PDF (5 User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,650 £Ü 8,317,000
PDF & Excel (Enterprise User License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅؽºÆ®ÀÇ Copy&Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.

ÁÖÀÇ : ¶óÀ̼±½º¿¡ µû¶ó ÀÚ·á ÀÌ¿ë ¹× Àμ⠵ Á¦¾àÀÌ ÀÖÀ» ¼ö ÀÖ½À´Ï´Ù.
ÀÚ¼¼ÇÑ ³»¿ëÀº ¶óÀ̼±½º ¼³¸í¹®( )À» Âü°íÇÏ¿© Áֽñ⠹ٶø´Ï´Ù.



¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

º¸°í¼­ ÇÏÀ̶óÀÌÆ®

¸ÖƼÆĶó¹ÌÅÍ È¯ÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ(Multiparameter Patient Monitoring System) ½ÃÀå ±Ô¸ð´Â 2022³â 120¾ï 5,040¸¸ ´Þ·¯ ±Ô¸ð¿¡ ´ÞÇß½À´Ï´Ù. 2023³âºÎÅÍ 2030³â±îÁö 6.1%ÀÇ CAGR·Î ¼ºÀåÇÏ¿© È®´ëµÉ Àü¸ÁÀÔ´Ï´Ù.

¸ÖƼÆĶó¹ÌÅÍ È¯ÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀå - ½ÃÀå ¿ªÇÐ:

¸¸¼ºÁúȯ À¯º´·ü »ó½Â, ¿Ü°ú ¼ö¼ú °Ç¼ö Áõ°¡, °í·ÉÈ­ µîÀÌ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â Å« ¿äÀÎÀÔ´Ï´Ù.

¸ÖƼÆĶó¹ÌÅÍ È¯ÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛÀº ¸¸¼º Áúȯ °ü¸®, ¼ö¼ú ¾ÈÀü °³¼±, ³ëÈ­ »çȸ °Ç°­ ¸ð´ÏÅ͸µ¿¡ ÇʼöÀûÀÔ´Ï´Ù. ¸¸¼º Áúȯ Áõ°¡´Â °Ç°­ °ü¸®¿¡¼­ ¸ÖƼÆĶó¹ÌÅÍ È¯ÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ °¡Ä¡¸¦ º¸¿©ÁÝ´Ï´Ù. ÀÌ·¯ÇÑ ½Ã½ºÅÛÀº Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µÀ» Á¦°øÇÏ°í Áúº´ °ü¸®¿¡ ±â¿©Çϸç ȯÀÚ ¿ø°Ý ¸ð´ÏÅ͸µÀ» °¡´ÉÇÏ°Ô Çϸç Áß¿ä »ç°Ç Á¶±â ¹ß°ß¿¡ µµ¿òÀÌ µË´Ï´Ù. National health council¿¡ µû¸£¸é, ÀϹÝÀûÀ¸·Î ºÒÄ¡º´À¸·Î ÇöÀçµµ ÁøÇà ÁßÀÎ ¸¸¼º ÁúȯÀº ¾à 1¾ï 3,300¸¸ ¸íÀÇ ¹Ì±¹ÀÎÀ» ¾Î°í ÀÖÀ¸¸ç, ÀÌ´Â ÀÌ ³ª¶ó ÃÑ Àα¸ 40% ÀÌ»ó¿¡ ÇØ´çÇÕ´Ï´Ù. 2020³â ÀÌ ¼öÄ¡´Â 1¾ï 5,700¸¸ ¸íÀ¸·Î ´Ã¾î³ª°í, 8,100¸¸ ¸íÀÌ ¿©·¯ Áúº´À» ¾Î°í ÀÖ´Ù°í ¿¹ÃøµË´Ï´Ù. °í·ÉÈ­ »çȸ´Â »ýü ½ÅÈ£¸¦ ¸ð´ÏÅ͸µÇÏ°í Á¤»ó ¹üÀ§ ¹þ¾î³ª´Â °ÍÀ» °¨ÁöÇϱâ À§ÇØ ¸ÖƼÆĶó¹ÌÅÍ È¯ÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛÀÌ ÇʼöÀûÀÔ´Ï´Ù. ¹«¼± ¿¬°á, ¼¾¼­ ¼ÒÇüÈ­, µ¥ÀÌÅÍ ºÐ¼® ¾Ë°í¸®Áò °³¼± µî ±Þ¼ÓÇÑ ±â¼ú °³¼±À¸·Î ´ÙÁß ÆĶó¹ÌÅÍ È¯ÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ÀáÀç·ÂÀÌ Å©°Ô È®´ëµË´Ï´Ù. ±×·¯³ª ¸ð´ÏÅ͸µ ½Ã½ºÅÛ À¯Áö º¸¼ö ºñ¿ëÀÌ ³ô´Ù´Â °ÍÀº ¸ÖƼÆĶó¹ÌÅÍ È¯ÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀåÀ» ¾ïÁ¦ÇÕ´Ï´Ù.

¸ÖƼÆĶó¹ÌÅÍ È¯ÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀå - ÁÖ¿ä ÅëÂû:

¸ÖƼÆĶó¹ÌÅÍ È¯ÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀå - ¼¼ºÐÈ­ ºÐ¼® :

¼¼°èÀÇ ¸ÖƼÆĶó¹ÌÅÍ È¯ÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀåÀº ÁßÁõµµ ¼öÁØ, ÀåÄ¡, ÃÖÁ¾ »ç¿ëÀÚ, ¹× Áö¿ª¿¡ µû¶ó ºÐÇҵ˴ϴÙ.

½ÃÀåÀº ½É°¢µµ ¼öÁØ¿¡ µû¶ó ³ôÀ½, Áß°£, ³·À½ ¼¼ °¡Áö ¹üÁÖ·Î ³ª´¹´Ï´Ù. ³ôÀº °­µµ ¼öÁØÀº ½ÃÀå ¼ºÀåÀ» Áö¹èÇÕ´Ï´Ù. ¸ÖƼÆĶó¹ÌÅÍ È¯ÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛÀº ȯÀÚ »ýü ½ÅÈ£¸¦ öÀúÇÏ°í Áö¼ÓÀûÀ¸·Î ¸ð´ÏÅ͸µÇÏ¿© Àû½Ã¿¡ °³ÀÔÀ» °¡´ÉÇÏ°Ô ÇÏ°í ȯÀÚ °á°ú¸¦ °³¼±Çϱâ À§ÇØ °íµµ ±Þ¼º±â ȯ°æÀÇ ÇʼöÀûÀÎ ¿ªÇÒÀ» ¼öÇàÇÕ´Ï´Ù.

½ÃÀåÀº Àåºñ¿¡ µû¶ó µÎ °¡Áö ¹üÁÖ·Î ³ª´¹´Ï´Ù. ÈÞ´ë¿ë ¹× °íÁ¤ÇüÀÔ´Ï´Ù. ÈÞ´ë¿ë ½ÃÀåÀ» µ¶Á¡ÇÏ°í ÀÖ¾î ¿¹Ãø ±â°£ µ¿¾È¿¡µµ ±× ¿ìÀ§¼ºÀº À¯ÁöµÉ Àü¸ÁÀÔ´Ï´Ù. ÈÞ´ë¿ë ´ÙÁß ÆĶó¹ÌÅÍ È¯ÀÚ ¸ð´ÏÅ͸µ ±â±â´Â Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µÀÌ ÇÊ¿äÇÑ È¯ÀÚ°¡ À̵¿ÇØ¾ß Çϰųª ±âÁ¸°ú´Â ´Ù¸¥ ÀÓ»ó ȯ°æ ¸ð´ÏÅ͸µÀÌ ÇÊ¿äÇÑ °æ¿ì¿¡ ƯÈ÷ À¯¿ëÇÕ´Ï´Ù.

½ÃÀåÀº ÃÖÁ¾ »ç¿ëÀÚº° º´¿ø, ÀçÅÃÄ¡·á, ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC) µîÀ¸·Î ºÐ·ùµË´Ï´Ù. º´¿øÀÌ ½ÃÀå ¼ºÀåÀ» Áö¹èÇÏ°í ÀÖ½À´Ï´Ù. ÈÞ´ë¿ë ´ÙÁß ÆĶó¹ÌÅÍ È¯ÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛÀº ȯÀÚ°¡ Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µÀ» ÇÊ¿ä·Î ÇÏÁö¸¸ À̵¿ÀÌ ÇÊ¿äÇÑ °æ¿ì³ª ±âÁ¸°ú´Â ´Ù¸¥ ÀÓ»ó ȯ°æ ¸ð´ÏÅ͸µÀÌ ÇÊ¿äÇÑ °æ¿ì¿¡ ƯÈ÷ À¯¿ëÇÕ´Ï´Ù.

¸ÖƼÆĶó¹ÌÅÍ È¯ÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀå - Áö¸®Àû Àü¸Á:

Áö¸®ÀûÀ¸·Î, ½ÃÀåÀº ºÏ¹Ì, ¶óƾ¾Æ¸Þ¸®Ä«, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«À¸·Î ÆÛÁ® ÀÖ½À´Ï´Ù. ÀÌ Áö¿ªÀº ºñÁî´Ï½º¸¦ Á¦°øÇÏ´Â ±¹°¡º°·Î ´õ ³ª´¹´Ï´Ù. ºÏ¹Ì´Â ÀÇ·áºñ Áõ°¡, ÷´Ü ȯÀÚ ¸ð´ÏÅ͸µ Á¦Ç° Á¦°øÀ» À§ÇÑ À̴ϼÅƼºê Áõ°¡, °ü¹Î ÆÄÆ®³Ê½ÊÀ» ÅëÇØ ¸ÖƼÆĶó¹ÌÅÍ È¯ÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀå ¼ºÀåÀ» Áö¹èÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¹Ì±¹ ÀÇ»çȸ¿¡ µû¸£¸é ¹Ì±¹ ÀÇ·áºñ´Â 2021³â 2.7% Áõ°¡ÇÑ 4Á¶ 3,000¾ï ´Þ·¯, ±¹¹Î 1Àδç 1¸¸ 2,914 ´Þ·¯ ±Ô¸ð¿¡ ´ÞÇß½À´Ï´Ù. ÀÌ ¼ºÀå·üÀº 2020³â(10.3%)º¸´Ù »ó´çÈ÷ ³·½À´Ï´Ù. ÀÌ ÁöÃâÀÇ »ó´çÇÑ °¨¼ÓÀº À¯Çà °ü·Ã Á¤ºÎ ÁöÃâ °¨¼Ò°¡ 2020³âºÎÅÍ Ä¡·á Áö¿¬°ú ¼ö¿ä °í°¥·Î ÀÎÇØ È¸º¹µÈ ÀÇ·áÇ°°ú ¼­ºñ½º ÀÌ¿ë Áõ°¡¸¦ »ó¼âÇ߱⠶§¹®ÀÔ´Ï´Ù. À¯·´Àº ¸ÖƼÆĶó¹ÌÅÍ È¯ÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ¶Çº° Áß¿ä ½ÃÀåÀÔ´Ï´Ù. ÀÌ Áö¿ªÀº °Ç°­ °ü¸® ±â¼ú µµÀÔ¿¡ ÁßÁ¡À» µÎ°í ¸Å·ÂÀûÀÎ »óȯ ±ÔÁ¦¸¦ Á¦°øÇϱ⠶§¹®¿¡ ÀÌ·¯ÇÑ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ¼ö¿ä¸¦ °ßÀÎÇÏ°í ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº ¾ÕÀ¸·Î ¼ö³â°£ ±Þ¼ÓÇÑ ½ÃÀå ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù.

¸ÖƼÆĶó¹ÌÅÍ È¯ÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀå - °æÀï ±¸µµ:

¸ÖƼÆĶó¹ÌÅÍ È¯ÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀåÀº °æÀïÀÌ Ä¡¿­ÇÏ°í ¼¼°èÀûÀ¸·Î À¯¸íÇÑ °æÀï»ç°¡ ¿©·¯ ÁøÃâÇÏ°í ÀÖ½À´Ï´Ù. Á¦Á¶¾÷ü´Â ´Ù¾çÇÑ ÀÇ·á ȯ°æ ¿ä±¸ »çÇ×À» ÃæÁ·Çϱâ À§ÇØ ´Ù¾çÇÑ ±â´É°ú ±â´ÉÀ» °®Ãá ¸ÖƼÆĶó¹ÌÅÍ È¯ÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ±¤¹üÀ§ÇÑ ¿É¼ÇÀ» Á¦°øÇÕ´Ï´Ù. °¢ Á¦Á¶¾÷ü´Â °æÀï·ÂÀ» À¯ÁöÇϱâ À§ÇØ Á¦Ç° Çõ½Å, Àü·« ÆÄÆ®³Ê½Ê, M&A ¹× ¼¼°èÀûÀÎ Á¸Àç È®´ë¿¡ ÁÖ·ÂÇÏ°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î 2022³â 8¿ù 31ÀÏ, ÀÇ·á ±â¼ú ¼¼°èÀÇ ¸®´õÀÎ ¸ÞµåÆ®·Î´Ð plc´Â Áö¼ÓÀûÀÎ °Ç°­ ¸ð´ÏÅ͸µ ¹× ÀÓ»ó ÀÎÅÚ¸®Àü½º ±â¾÷ÀÎ ¹ÙÀÌ¿À ÀÎÅÚ¸®Àü½º¿Í "Áö¼ÓÀûÀÎ ¿¬°á ¸ð´ÏÅ͸µÀ» À§ÇÑ ¸ÖƼÆĶó¹ÌÅÍ ¿þ¾î·¯ºí"¹ÙÀÌ¿À ¹öÆ° ¹Ì±¹ º´¿ø ¹× 30ÀÏ ÈÄ º´¿ø Áý±îÁöÀÇ µ¶Á¡ ÆÇ¸Å±Ç Àü·« ÆÄÆ®³Ê½ÊÀ» ü°áÇß´Ù°í ¹ßÇ¥Çß½À´Ï´Ù.

ÃÖ±Ù µ¿Çâ

2023³â 06¿ù 01ÀÏ-°Ç°­ ±â¼ú ¼¼°èÀÇ ¸®´õÀÎ ·Î¾â Philips¿Í ¼¼°èÀÇ ÀÇ·á±â¼ú ±â¾÷ÀÎ ¸¶½Ã¸ð´Â ÃÖ±Ù Philips ȯÀÚ¿ë ¸ð´ÏÅÍÀÎ ÀÎÅÚ¸®ºä MX750 ¹× MX850 ¼¼µå¶óÀÎ ³ú ±â´É ¸ð´ÏÅ͸µ, ±¹¼Ò ¿Á½Ã¸ÞÆ®¸®( O3), CO2 ÃøÁ¤ È°¼ºÈ­¸¦ Çã¿ëÇÏ´Â FDA ½ÂÀÎÀ» ¹ßÇ¥Çß½À´Ï´Ù.

¿¬±¸ ÁÖ¿ä Ư¡

¸ñÂ÷

Á¦1Àå ´ÙÁß ÆĶó¹ÌÅÍ È¯ÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀå ÁÖ¿ä ¿ä¾à

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ´ÙÁß ÆĶó¹ÌÅÍ È¯ÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ÁÖ¿ä ½ÃÀå µ¿Çâ

Á¦4Àå ´ÙÁß ÆĶó¹ÌÅÍ È¯ÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ¾÷°è Á¶»ç

Á¦5Àå ´ÙÁß ÆĶó¹ÌÅÍ È¯ÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀå : COVID-19 ¿µÇ⠺м®

Á¦6Àå ´ÙÁß ÆĶó¹ÌÅÍ È¯ÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀå »óȲ

Á¦7Àå ´ÙÁß ÆĶó¹ÌÅÍ È¯ÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀå - ÁßÁõµµ ¼öÁغ°

Á¦8Àå ´ÙÁß ÆĶó¹ÌÅÍ È¯ÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀå - ÀåÄ¡º°

Á¦9Àå ´ÙÁß ÆĶó¹ÌÅÍ È¯ÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀå - ÃÖÁ¾ »ç¿ëÀÚº°

Á¦10Àå ´ÙÁß ÆĶó¹ÌÅÍ È¯ÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀå - Áö¿ªº°

Á¦11Àå ÁÖ¿ä º¥´õ ºÐ¼®-´ÙÁß ÆĶó¹ÌÅÍ È¯ÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ¾÷°è

Á¦12Àå ¾Ö³Î¸®½ºÆ® Àü¸Á

NJH 23.08.21
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

REPORT HIGHLIGHT

The Multiparameter Patient Monitoring System Market size was valued at USD 12,050.4 Million in 2022, expanding at a CAGR of 6.1% from 2023 to 2030.

A Multiparameter patient monitoring system is a medical device that is used in hospitals to continually monitor and measure numerous physiological parameters of patients. These devices gather and report sampled values like temperature and blood pressure as well as continuous variables like an ECG or EEG. These patient monitors can display information, transmit warning signals to staff members, gather and disseminate radiological data, and monitor a variety of life support systems, among other things. For these patient monitors, reliability, high-resolution screens, precision, power management, and security are just a few of the important factors. These systems must have the computing capability necessary to simultaneously acquire, integrate, filter, and interpret data from several biotelemetry sources while also displaying data, transferring data from the network, and providing alarm conditions.

Multiparameter Patient Monitoring System Market- Market Dynamics:

Rising Prevalence of chronic diseases, the rise in the number of surgical procedures, and the aging population are significant factors driving the market growth.

Multiparameter patient monitoring systems are essential in the management of chronic diseases, the improvement of surgical safety, and the monitoring of the health of the aging population. A rise in chronic diseases indicates the value of Multiparameter patient monitoring systems in healthcare. These systems provide continuous monitoring, contribute to disease management, allow for remote patient monitoring, and help to detect key occurrences early. According to the National health council, generally incurable and ongoing, chronic diseases affect approximately 133 million Americans, representing more than 40% of the total population of this country. By 2020, that number is projected to grow to an estimated 157 million, with 81 million having multiple conditions. In an aging population, Multiparameter patient monitoring systems are essential for monitoring vital signs and detecting deviations from normal ranges. Rapid technological improvements, including wireless connectivity, sensor shrinking, and improved data analysis algorithms, have significantly expanded the potential of Multiparameter patient monitoring systems. However, the high maintenance cost of monitoring systems restrains the Multiparameter Patient Monitoring System Market.

Multiparameter Patient Monitoring System Market- Key Insights:

Multiparameter Patient Monitoring System Market- Segmentation Analysis:

The Global Multiparameter Patient Monitoring System Market is segmented on the basis of Acuity Level, Device, End-user, and Region.

The market is divided into three categories based on Acuity Level: High, Medium, and Low. High Acuity Level dominates the market growth. Multiparameter patient monitoring systems play an essential role in high-acuity settings because they provide thorough and continuous monitoring of patients' vital signs, allowing for timely intervention and improving patient outcomes.

The market is divided into two categories based on Devices: Portable and Fixed. Portable dominates the market and is likely to maintain its dominance during the forecast period. Portable Multiparameter patient monitoring devices are especially useful when patients who require continuous monitoring currently have to travel or when monitoring is required in non-traditional clinical settings.

The market is divided into two categories based on End-User: Hospitals, Homecare Settings, Ambulatory Surgical Centers, and Others. Hospitals dominate the market growth. Portable Multiparameter patient monitoring devices are especially useful in circumstances where patients require continuous monitoring yet need to travel or where monitoring is required in non-traditional clinical settings.

Multiparameter Patient Monitoring System Market- Geographical Insights:

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the growth of the Multiparameter Patient Monitoring System market, due to the higher healthcare expenditure, growing initiatives to offer advanced patient monitoring products, and private-public partnerships. According to American Medical Association, Health spending in the U.S. increased by 2.7% in 2021 to USD 4.3 trillion or USD12,914 per capita. This growth rate is substantially lower than in 2020 (10.3% percent). This substantial deceleration in spending can be attributed to the decline in pandemic-related government expenditures offsetting increased utilization of medical goods and services that rebounded due to delayed care and pent-up demand from 2020. Europe is another significant market for Multiparameter patient monitoring systems. The region places a major emphasis on healthcare technology adoption and provides attractive reimbursement regulations, which drives demand for these monitoring systems. The Asia Pacific region is expected to witness rapid market growth in the coming years.

Multiparameter Patient Monitoring System Market- Competitive Landscape:

The market for Multiparameter Patient Monitoring Systems is highly competitive, with several well-known competitors operating globally, due to the ongoing growth in demand for these systems in healthcare in the upcoming years. The manufacturers provide a broad selection of Multiparameter patient monitoring systems with diverse features and functionalities to meet the requirements of various healthcare environments. They focus on product innovation, strategic partnerships, mergers and acquisitions, and expanding their global presence to maintain a competitive edge. For Example, on August 31, 2022, Medtronic plc, a global leader in healthcare technology, nowadays announced it has entered into a strategic partnership with BioIntelliSense, a continuous health monitoring and clinical intelligence company, for the exclusive U.S. hospital and 30-day post-acute hospital to home distribution rights of the BioButton multi-parameter wearable for continuous, connected monitoring.

Recent Developments:

Jun 01, 2023, - Royal Philips, a global leader in health technology, and Masimo, a global medical technology company, nowadays announced FDA clearance allowing the activation of SedLine Brain Function Monitoring, Regional Oximetry (O3), and CO2 measurements in Philips Patient Monitors - IntelliVue MX750 and MX850.

Key features of the study:

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL MULTIPARAMETER PATIENT MONITORING SYSTEM MARKET KEY PLAYERS

GLOBAL MULTIPARAMETER PATIENT MONITORING SYSTEM MARKET, BY ACUITY LEVEL

GLOBAL MULTIPARAMETER PATIENT MONITORING SYSTEM MARKET, BY DEVICE

GLOBAL MULTIPARAMETER PATIENT MONITORING SYSTEM MARKET, BY END-USER

GLOBAL MULTIPARAMETER PATIENT MONITORING SYSTEM MARKET, BY REGION

Table of Contents

1. Multiparameter Patient Monitoring System Market Overview

2. Executive Summary

3. Multiparameter Patient Monitoring System Key Market Trends

4. Multiparameter Patient Monitoring System Industry Study

5. Multiparameter Patient Monitoring System Market: COVID-19 Impact Analysis

6. Multiparameter Patient Monitoring System Market Landscape

7. Multiparameter Patient Monitoring System Market - By Acuity Level

8. Multiparameter Patient Monitoring System Market - By Device

9. Multiparameter Patient Monitoring System Market - By End-User

10. Multiparameter Patient Monitoring System Market- By Geography

11. Key Vendor Analysis- Multiparameter Patient Monitoring System Industry

12. 360 Degree Analyst View

13. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â